This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AI-powered scribes are proving their ability to dramatically reduce clinician burnout, but their financial impact is unclear, according to research from the Peterson Health Technology Institute. The post Why Hospitals Are Scaling AI Scribes, Even Though They Dont Reduce Costs appeared first on MedCity News.
As healthcare professionals, we know firsthand how demanding and rewarding our careers can be. But between long shifts, continuing education, and patient care, theres often little time left to focus on something equally important: your financial future. Thats the benefit of InCrowd surveys. You are able to earn extra income simply by sharing your professional insights all on your own schedule.
As the FDAs top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agencys ability to review and potentially approve such treatments. The post Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions appeared first on MedCity News.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Todd Crowder’s path into medical sales wasn’t just a career choice it was a legacy in the making. Growing up with a father who built a prolific career at Ethicon, Todd was immersed in the industry from an early age. But instead of simply following in his father’s footsteps, he forged his own path, bringing a unique blend of military discipline, strategic thinking, and entrepreneurial drive into the world of medical sales.
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
True patient engagement creates ripple effects that transform both clinical outcomes and business results in a measurable way. Measuring engagement isnt just about numbersits about the lives that are touched and the improvements made through strategic, thoughtful approaches to patient communication. The concept of patient engagement has evolved significantly over the past 25 years.
Trimming your marketing budget might seem like a quick way to cut costs, but it can hurt your healthcare business more than you thinkespecially during economic uncertainty. While the U.S. economy remains numerically strong, 53%of Americans think its on the wrong track. With uncertainty surrounding impending tariffs, inflation, a tightening labor market, and rising healthcare costs, consumer confidence is beginning to dip.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
When employees feel supported in every aspect of their lives, they bring their full potential to work creating value that resonates throughout the organization. Here are four ways culture-driven benefits deliver meaningful returns, The post Culture-Driven Benefits: The Smartest Investment for Retention and Productivity appeared first on MedCity News.
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.
Why Real, Measurable Impact Can Only Come from Getting Close The advertising landscape is undergoing a seismic shift. As network agencies navigate uncharted territoriesmerging, rebranding, mounting margin pressures, and laying off thousandsthey are being forced to spend time and energy on things other than serving clients and growing their talent base.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI in Rare Form of Obesity Rooted in a Dysregulated Brain Pathway appeared first on MedCity News.
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. It has transformed into a dynamic dialogue that empowers individuals, personalizes content, and integrates cutting-edge digital tools. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Digitas Healths Scott Raidel and Erica Rivera give us their insight on the future of blended learning for healthcare providers. SCOTT RAIDEL Chief Medical Officer Digitas Health ERICA RIVERA SVP, Engagement Strategy Digitas Health At the forefront of the industrys work, there is a desire to develop effective and tangible learning strategies for healthcare providers (HCPs).
An innovative air sampling system could improve the efficiency and accuracy of rapid detection for airborne bacteria in the environment, new research suggests. Eraslan-Gltekin et al. developed an air sampling system to collect aerosolised bacterial samples in a liquid medium. By utilising an improved air sampler with loop-mediated isothermal amplification (LAMP) as a rapid nucleic acid amplification method, the proposed method provides a cost-effective and reliable approach to monitoring airborn
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimers disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier appeared first on MedCity News.
Is your marketing team juggling too many reports with too little clarity? In today’s complex digital advertising landscape, PPC reporting has evolved from single-platform insights into a multifaceted analytics necessity. For pharmaceutical marketing executives, the challenge is even more pronounced: how to unify and interpret disparate campaign data from search engines like Google and social channels such as LinkedIn and Facebook?
Why Pharmas AI Strategy Must Evolve AI is everywhere in pharma. Companies are running pilots, testing AI in sales, marketing, and market access. Some are seeing results; many are not. The industry is at a breaking point. Over the last year or so, AI has been treated as an experimentpromising but not critical. That mindset is shifting as AI is now creating genuine business outcomes not only in drug discovery but also in commercialization.
A novel design approach could improve aseptic processing for cell therapy manufacturing, research suggests. In their Regenerative Therapy paper, Furomitsu et al. proposed an environment by designing an air mass balance in an aseptic processing area. The approach used open and closed system equipment consisting of critical processing zones, such as biosafety cabinets and isolator systems.
We must consider the broader social and structural context recognizing that poverty, social deprivation, and economic instability are not merely relevant factors, but necessary considerations in developing effective, equitable interventions. The post From Transfers to Treatment: Bridging Social Policy and Substance Use Treatment appeared first on MedCity News.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Can Automating Patient Intake Help Healthcare Providers? Manual patient intake is a burden. Its slow and prone to errors. This can mean long wait times for patients, but for healthcare providers, it can mean missing data, extra costs, and compliance risks. Automation solves the problem by streamlining data capture, improving accuracy, and increasing security.
A Smarter Approach to Pharma Marketing Pharma marketing is evolving rapidly as artificial intelligence (AI) and analytics make it easier to interpret health datasuch as insurance claims, lab results, and patient recordswhile also leveraging engagement data to refine outreach strategies. Rather than relying on broad outreach, marketers can now use data-driven insights to identify the right audience and craft messages that resonate.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content